Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo J G Snippert

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Nature Cell Biology|September 28, 2018
Long noncoding RNAs in gut stem cellsPantelis Hatzis, Hugo J G Snippert
Cell Stem Cell|July 8, 2017
Expanding the Tissue Toolbox: Deriving Colon Tissue from Human Pluripotent Stem CellsLotte Bruens, Hugo J G Snippert
STAR Protocols|December 30, 2020
Introducing the Stem Cell ASCL2 Reporter STAR into Intestinal OrganoidsMaria C Heinz, Koen C Oost, Hugo J G Snippert
Trends in Cancer|February 17, 2020
Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF VariantsJasmin B Post, Jeanine M L Roodhart, Hugo J G Snippert
Nucleic Acids Research|June 30, 2018
How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editingYannik Bollen, Jasmin Post, Bon-Kyoung Koo, et al.
Oncotarget|March 13, 2019
CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibitionJasmin B Post, Nizar Hami, Alexander E E Mertens, et al.
Developmental Cell|August 26, 2020
Intestinal Regeneration: Regulation by the MicroenvironmentJoris H Hageman, Maria C Heinz, Kai Kretzschmar, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Efficacy and safety in early-phase clinical trials for refractory colorectal cancer: A meta-analysisLidwien P Smabers, Maarten A Huismans, Niels van Nieuwenhuijzen, et al.
Iscience|July 21, 2025
BRAF<sup>V600E</sup> augments WNT signaling in colorectal cancer via aberrant DNA methylationLayla El Bouazzaoui, Jeroen M Bugter, Emre Küçükköse, et al.
Iscience|July 18, 2025
BRAF<sup>V600E</sup> maintains the CpG island methylator phenotype, and DNA methylation of PRC2 targets genes in colon cancerLayla El Bouazzaoui, Jeroen M Bugter, Emre Küçükköse, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Nature Cell Biology|September 28, 2018
Long noncoding RNAs in gut stem cellsPantelis Hatzis, Hugo J G Snippert
Cell Stem Cell|July 8, 2017
Expanding the Tissue Toolbox: Deriving Colon Tissue from Human Pluripotent Stem CellsLotte Bruens, Hugo J G Snippert
STAR Protocols|December 30, 2020
Introducing the Stem Cell ASCL2 Reporter STAR into Intestinal OrganoidsMaria C Heinz, Koen C Oost, Hugo J G Snippert
Trends in Cancer|February 17, 2020
Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF VariantsJasmin B Post, Jeanine M L Roodhart, Hugo J G Snippert
Nucleic Acids Research|June 30, 2018
How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editingYannik Bollen, Jasmin Post, Bon-Kyoung Koo, et al.
Oncotarget|March 13, 2019
CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibitionJasmin B Post, Nizar Hami, Alexander E E Mertens, et al.
Developmental Cell|August 26, 2020
Intestinal Regeneration: Regulation by the MicroenvironmentJoris H Hageman, Maria C Heinz, Kai Kretzschmar, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Efficacy and safety in early-phase clinical trials for refractory colorectal cancer: A meta-analysisLidwien P Smabers, Maarten A Huismans, Niels van Nieuwenhuijzen, et al.
Iscience|July 21, 2025
BRAF<sup>V600E</sup> augments WNT signaling in colorectal cancer via aberrant DNA methylationLayla El Bouazzaoui, Jeroen M Bugter, Emre Küçükköse, et al.
Iscience|July 18, 2025
BRAF<sup>V600E</sup> maintains the CpG island methylator phenotype, and DNA methylation of PRC2 targets genes in colon cancerLayla El Bouazzaoui, Jeroen M Bugter, Emre Küçükköse, et al.
Pageof 3